Combination Chemotherapy in Patients With Newly Diagnosed BPDCN

Clinical trial NCT03599960 · UNKNOWN

Trial details

NCT number: NCT03599960
Sponsor: Centre Hospitalier Universitaire de Besancon
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Start date: 2019-05-02
Primary completion: 2023-02-13
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.